Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | DRD4 | P21917 | 1/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.48 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.45 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.45 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.45 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.45 |
| ▸ | PNMT | P11086 | 1/20 | 0.44 |
| ▸ | CD44 | P16070 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indoline SCHEMBL29360339 | 0.97 | — | — | |
| Indoline SCHEMBL5629 | 0.97 | — | — | |
| Indoline SCHEMBL10723456 | 0.95 | HTR2C (0.50) | HTR2CDRD2DRD4PDPK1PARP1 | |
| Indoline SCHEMBL1085136 | 0.95 | HTR2C (0.50) | HTR2CDRD2DRD4PDPK1PARP1 | |
| Indoline SCHEMBL2925258 | 0.95 | HTR2C (0.50) | HTR2CDRD2DRD4PDPK1PARP1 | |
| Indoline SCHEMBL23295083 | 0.95 | HTR2C (0.50) | HTR2CDRD2DRD4PDPK1PARP1 | |
| Indoline SCHEMBL6872936 | 0.95 | HTR2C (0.50) | HTR2CDRD2DRD4PDPK1PARP1 | |
| Indoline SCHEMBL4903255 | 0.95 | HTR2C (0.50) | HTR2CDRD2DRD4PDPK1PARP1 | |
| Indoline SCHEMBL1587228 | 0.95 | HTR2C (0.50) | HTR2CDRD2DRD4PDPK1PARP1 | |
| Indoline SCHEMBL11401846 | 0.95 | HTR2C (0.50) | HTR2CDRD2DRD4PDPK1PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042736-A1 | COMPOSITIONS AND METHODS FOR MAKING SCYTONEMIN AND ITS ANALOGS AND DERIVATIVES | Board of Regents of Nevada System of Higher Education on behalf of the University of Nevada Reno (US) | 2026-02-12 | — | — | US | disclosed |
| CN-111892528-B | Preparation method of 7-amide indole compound | 温州医科大学 | 2022-01-04 | — | — | CN | disclosed |
| CN-113735832-A | Preparation method of 7-succinimide indole compound | 温州医科大学 | 2021-12-03 | — | — | CN | disclosed |
| CN-111892528-A | Preparation method of 7-amide indole compound | 温州医科大学 | 2020-11-06 | — | — | CN | disclosed |
| WO-2000006582-A9 | TRIMERIC AND POLYMERIC ALKALOIDS | GOLDSMITH SEEDS INC (US) | 2000-08-03 | — | — | WO | disclosed |
| WO-2000006582-A1 | TRIMERIC AND POLYMERIC ALKALOIDS | GOLDSMITH SEEDS, INC. (US) | 2000-02-10 | — | — | WO | disclosed |
| US-5905148-A | Photochromic spirooxazine polysiloxanes | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1999-05-18 | — | — | US | disclosed |
| US-5473068-A | Photochromic spirooxazine monomers and polysiloxanes | YEDA RESEARCH AND DEVELOPMENT CO. LTD. AT THE WEIZMANN INSTITUTE OF SCIENCE (IL) | 1995-12-05 | — | — | US | disclosed |
| US-5338845-A | Analgesics, antiinflammatory agent | STERLING WINTHROP INC. (US) | 1994-08-16 | — | — | US | disclosed |
| US-5322945-A | Photochromic spirooxazine monomers and polysiloxanes | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1994-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042736-A1 | COMPOSITIONS AND METHODS FOR MAKING SCYTONEMIN AND ITS ANALOGS AND DERIVATIVES | TDO2, SCO2, TPH1 | HTR2C 115/4885DRD2 659/4885DRD4 1606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.